ICT-supported Multidimensional Approach for Frailty Screening in Community-dwelling Individuals Aged ≥ 65 Years (SUNFRAIL+)

September 11, 2023 updated by: Maddalena Illario, Federico II University

Approccio Multidimensionale Supportato Dalle ICT Per lo Screening Della fragilità Nei Soggetti di età ≥ 65 Anni Che Vivono in comunità - SUNFRAIL+

SUNFRAIL+ is a prospective observational cohort study aimed to carry out a multidimensional assessment of community-dwelling older adults, through an IT platform, which allows to connect the items of the SUNFRAIL frailty assessment tool with a cascading multidimensional in-depth assessment of the bio-psycho-social domains of frailty. It is a multicentric study. Seven centres will administer SUNFRAIL questionnaire to 100 older adults each and, according to the specific "alerts" triggered by the answers provided, older adults will be subjected to one or more validated in-depth tests in order to perform further diagnostic or dimensional evaluations.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

700

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Maddalena Illario, PhD
  • Phone Number: +390817464211
  • Email: illario@unina.it

Study Contact Backup

Study Locations

      • Busto Arsizio, Italy
        • Recruiting
        • Azienda Socio Sanitaria Territoriale della Valle Olona
        • Contact:
          • Marino Dell'Acqua
      • Cuneo, Italy
        • Recruiting
        • Azienda Sanitaria Locale Cuneo 1
        • Contact:
          • Paola Obbia
      • Genova, Italy
        • Recruiting
        • Azienda Sociosanitaria Ligure n. 4
        • Contact:
          • Walter Aronni
      • Lucca, Italy
        • Recruiting
        • Azienda Unità Sanitaria Locale Nord-Ovest
        • Contact:
          • Moira Borgioli
      • Napoli, Italy
        • Recruiting
        • Azeidna Ospedaliera Universitaria Federico II
        • Contact:
          • Maddalena Illario
      • Reggio Calabria, Italy
        • Recruiting
        • Cooperativa Sociale "Res Omnia"
        • Contact:
          • Fortunata Denisi
      • Roma, Italy
        • Recruiting
        • Dipartimento di Biomedicina e Prevenzione dell'Università degli Studi di Roma Tor Vergata
        • Contact:
          • Giuseppe Liotta
      • Trento, Italy
        • Recruiting
        • Azienda Provinciale Socio-Sanitaria Trento
        • Contact:
          • Stefano Toccoli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

primary care clinic, community sample

Description

Inclusion Criteria:

  • Age ≥65 years;
  • Living at home;
  • accessing participating centres for social and healthcare services other than those covered by this study;
  • ability to sign the informed consent

Exclusion Criteria:

  • Age <65 years;
  • Residents in care facilities (hospital, nursing home);
  • have overt frailty or disability; are already enrolled in home care; are unable to understand the study aims and sign the informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
≥ 65 Community-dwelling older adults

Each Centre will administer SUNFRAIL frailty assessment tool to the enrolled older adults and, according to the specific "alerts" triggered by the answers provided, older adults will be subjected (at the same time or subsequently) to one or more validated in-depth tests (already included in the SUNFRAIL+ platform) in order to perform further diagnostic or dimensional evaluations.

During the observation phase, subjects will be given different health promotion activities, depending on the assessment.

During the follow-up phase, 6 months after enrolment, SUNFRAIL tool and in-depth tests will be administered again. In addition, during the follow up, the extent to which exposure to interventions has influenced the quality of life of older adults will be measured and the number of users enrolled by territorial services, based on user care needs. In addition, the level of satisfaction and usability of the SUNFRAIL+ solution by health and social care professionals will be measured.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improved quality of life
Time Frame: Month 14
Impact of early, integrated and simultaneous "taking care" by health system on the quality of life of community-dwelling older adults
Month 14
Appropriateness of care
Time Frame: Month 14
Level of appropriateness of care by the healthcare system
Month 14
Level of satisfaction of the health professionals
Time Frame: Month 14
Impact of the IT solution on the organization of services and the workload of professionals
Month 14

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Estimated)

February 28, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

December 1, 2022

First Submitted That Met QC Criteria

December 9, 2022

First Posted (Actual)

December 12, 2022

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 11, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 284/22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study protocol will be published on an open access scientific journal

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frail Elderly Syndrome

Clinical Trials on Frailty multidimensional assessment

Subscribe